Ospen (Phenoxymethylpenicillin Benzathine)

Phenoxymethylpenicillin Benzathine, the active ingredient in Ospen, is a beta‑lactam antibiotic presented as a benzathine salt for intramuscular injection use. It treats susceptible bacterial infections such as streptococcal pharyngitis and rheumatic fever prophylaxis in children and adults.

GNH USA supplies Ospen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Ospen is a penicillin‑type antibiotic that acts on Gram‑positive bacteria responsible for several common infections. - Streptococcal pharyngitis: reduces symptom duration and prevents complications. - Rheumatic fever prophylaxis: maintains low bacterial load to avert recurrence. - Skin and soft‑tissue infections caused by susceptible streptococci: aids bacterial eradication. - Early syphilis (primary and secondary): provides long‑acting antimicrobial coverage. - Community‑acquired pneumonia: contributes to pathogen clearance when indicated.

Adverse reactions to Ospen may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Injection site pain or erythema. - Nausea or mild gastrointestinal upset. - Diarrhea. - Transient rash. - Headache.

Serious or Rare Side Effects: - Anaphylaxis or severe allergic reaction. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hemolytic anemia. - Severe neutropenia. - Serum sickness‑like reactions.

Before initiating Ospen, clinicians should assess patient history and potential risk factors. - Allergy assessment: confirm no known hypersensitivity to penicillins. - Renal function: adjust if significant impairment is present. - Pregnancy status: weigh benefits against potential risks. - Concomitant antibiotics: avoid overlapping spectra that may increase toxicity. - Monitor for signs of superinfection: watch for new or worsening infections. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Ospen can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Methotrexate: increased risk of myelosuppression. - Oral anticoagulants (e.g., warfarin): enhanced anticoagulant effect. - All‑opurinol: heightened risk of rash.

Moderate Interactions (Monitor Closely): - Oral contraceptives: possible reduction in contraceptive efficacy. - Probenecid: may increase penicillin plasma levels. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): potential for renal impairment when combined with dehydration.